Nabumetone
Product Images NDC 66336-316

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 66336-316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Of Nabumetone (5276f530 14bc 492d 974b 913fd06bf52e 01)

Chemical structure of Nabumetone showing the molecular arrangement with a methoxy group, aromatic rings, and an acetyl side chain. The formula C15H16O2 and molecular weight 228.3 are noted below the diagram.*

FDA Label Image

6mna (5276f530 14bc 492d 974b 913fd06bf52e 02)

Chemical structure diagram of 6-methoxy-2-naphthylacetic acid (6MNA), the active metabolite of Nabumetone.*

FDA Label Image

Table 1 (5276f530 14bc 492d 974b 913fd06bf52e 03)

A data table comparing pharmacokinetic parameters of Nabumetone in young adult and elderly groups, showing Tmax, half-life (t1/2), steady-state clearance (CLss/F), and volume of distribution (Vdss/F) values with means, standard deviations, and sample sizes for each group.*

FDA Label Image

6mna Plasma Concentrations (5276f530 14bc 492d 974b 913fd06bf52e 04)

A line chart showing Nabumetone active metabolite (6MNA) plasma concentrations at steady state following once-daily dosing of Nabumetone at 1000 mg (n=31) and 2000 mg (n=12). The x-axis represents time in hours (0 to 70), and the y-axis shows concentration in mcg/mL (0 to 120). The graph includes mean concentrations with standard deviations (+2 SD and -2 SD) for both dosages, with annotations marking 1000 mg and 2000 mg dosage days.*

FDA Label Image

Metabolites (5276f530 14bc 492d 974b 913fd06bf52e 05)

A data table listing percentages of various metabolites and related compounds of nabumetone, including unchanged nabumetone, 6-methoxy-2-naphthylacetic acid (6MNA), conjugated metabolites, and unidentified minor metabolites, with a total dose percentage of 73%.*

FDA Label Image

Table 2 (5276f530 14bc 492d 974b 913fd06bf52e 06)

A data table presenting the number of patients with osteoarthritis (OA) and rheumatoid arthritis (RA) treated with various doses of Nabumetone (500 mg, 1000 mg, 1500 mg, and 2000 mg). The table also shows the mean and mode duration of treatment in years for both OA and RA patients at each dose level.*

FDA Label Image

Side Effects Table (5276f530 14bc 492d 974b 913fd06bf52e 07)

A drug facts text panel listing serious and other side effects associated with the drug Nabumetone. Serious side effects include heart attack, stroke, high blood pressure, heart failure from fluid retention, kidney and liver problems, bleeding, low red blood cells, and life-threatening reactions. Other side effects include stomach pain, constipation, diarrhea, gas, heartburn, nausea, vomiting, and dizziness.*

FDA Label Image

Get Emergency Help If You Experience These Symptoms (5276f530 14bc 492d 974b 913fd06bf52e 08)

A partial text panel listing warning signs related to emergency medical conditions, including shortness of breath, chest pain, weakness on one side of the body, slurred speech, and swelling of the face or throat. The text is presented as bullet points across two columns in a bordered box.*

FDA Label Image

Stop Nsaid If You Experience These Symptoms (5276f530 14bc 492d 974b 913fd06bf52e 09)

A text panel listing potential side effects or symptoms to watch for, including nausea, fatigue, itching, yellowing of skin or eyes, stomach pain, flu-like symptoms, vomiting blood, blood in bowel movements or black sticky stool, unusual weight gain, skin rash or blisters with fever, and swelling of extremities.*

FDA Label Image

Nsaid Medications That Need A Prescription (5276f530 14bc 492d 974b 913fd06bf52e 10)

A data table listing generic nonsteroidal anti-inflammatory drugs (NSAIDs) in one column paired with their corresponding tradenames in the adjacent column. It includes entries such as Nabumetone with the tradename Relafen, Ibuprofen with multiple tradenames including Motrin and Vicoprofen, and Naproxen with tradenames such as Naprosyn and Anaprox DS.*

FDA Label Image

Glenmark Logo (5276f530 14bc 492d 974b 913fd06bf52e 11)

FDA Label Image

Ndc 66336-0316-xx (Ndc 66336 0316 Xx Invagen)

Nabumetone 500 mg tablet label from Dispensing Solutions, Inc. Shows product name, strength, dosage form (tablets), and NDC 66336-0316-XX. Indicates prescription only (RX ONLY) and includes lot, expiration date placeholders, and usage notes. Mentions bulk source Invagen Pharmaceuticals and dispensing instructions with warnings to avoid alcohol, take with food, and keep out of children's reach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.